CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells

The Biochemical Journal
Ke GongWenhua Li

Abstract

CS055 (Chidamide/HBI-8000) is a novel benzamide-type HDACi (histone deacetylase inhibitor), which has entered Phase I clinical trials in the U.S. and Phase II/III in China. In the present study, we investigated the effects of CS055 on proliferation, differentiation and apoptosis in human leukaemia cell lines and primary myeloid leukaemia cells. The results showed that at low concentrations (<1 μM), CS055 induced G1 arrest. At moderate concentrations (0.5 μM-2 μM), CS055 induced differentiation, as determined by the increased expression of the myeloid differentiation marker CD11b. At relatively high concentrations (2 μM-4 μM), CS055 potently induced caspase-dependent apoptosis. Co-treatment with the ROS (reactive oxygen species) scavengers N-acetyl-L-cysteine or Tiron blocked CS055-induced cell differentiation and apoptosis, suggesting an essential role for ROS in these effects. Cytochrome c release and ROS-mediated mitochondrial dysfunction are involved in CS055-induced apoptosis of leukaemia. In addition to cell lines, CS055 also exhibits therapeutic effects in human primary leukaemia cells. Moreover, daily oral CS055 treatment of nude mice bearing HL60 cell xenografts suppressed tumour growth, induced tumour cell apoptosis an...Continue Reading

References

May 17, 2003·Cancer Biology & Therapy·Maria Eugenia Guicciardi, Gregory J Gores
Apr 27, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Qin C RyanEdward A Sausville
Jan 7, 2006·Nature Reviews. Cancer·Saverio Minucci, Pier Giuseppe Pelicci
Sep 7, 2006·Nature Reviews. Drug Discovery·Jessica E BoldenRicky W Johnstone
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Quang T LuongH Phillip Koeffler
Dec 1, 2006·Apoptosis : an International Journal on Programmed Cell Death·Yoshihide Tsujimoto, Shigeomi Shimizu
Mar 14, 2007·Apoptosis : an International Journal on Programmed Cell Death·S EmanueleG Tesoriere
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yukihiko KatoRoberto Pili
Oct 26, 2007·Journal of Medicinal Chemistry·Alexander Yurek-GeorgeA Ganesan
Dec 22, 2007·Nature Reviews. Molecular Cell Biology·Richard J Youle, Andreas Strasser
Mar 4, 2008·Trends in Cell Biology·Jerry E Chipuk, Douglas R Green
Jun 24, 2008·Nature Reviews. Molecular Cell Biology·Yong-Ling P OwTak W Mak
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jerry E ChipukDouglas R Green
Feb 21, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Min H Kang, C Patrick Reynolds
Feb 25, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xiaoqun DongDonghui Li
Mar 25, 2009·Neoplasia : an International Journal for Oncology Research·Yang YangWei-Guo Zhu
May 22, 2009·Journal of Cellular Biochemistry·P A Marks, W-S Xu
May 30, 2009·Nature Reviews. Drug Discovery·Dunyaporn TrachoothamPeng Huang
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ashraf BadrosSteven Grant
Jan 13, 2010·The Journal of Biological Chemistry·Roberto R RosatoSteven Grant
Jun 5, 2010·Cell Death and Differentiation·J L SardinaA Hernández-Hernández
Apr 14, 2011·The Biochemical Journal·Shefali KrishnaShazib Pervaiz
Jun 10, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sílvia Xargay-TorrentDolors Colomer

❮ Previous
Next ❯

Citations

Apr 12, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·You ZhouZhi-Qiang Ning
Jul 17, 2013·Biomedical Chromatography : BMC·Xianqin WangJianshe Ma
Oct 2, 2015·Investigational New Drugs·Diana MarkozashviliYegor S Vassetzky
Jun 25, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y ShiX Lu
Dec 30, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Bo Ra YouWoo Hyun Park
Mar 10, 2016·Expert Opinion on Investigational Drugs·Susmitha Apuri, Lubomir Sokol
Sep 28, 2016·Intractable & Rare Diseases Research·Xianping LuXinhao Wang
Feb 10, 2017·Medicinal Research Reviews·Chiara ZagniAntonio Rescifina
Jul 22, 2014·British Journal of Pharmacology·Laia Simó-Riudalbas, Manel Esteller
Mar 5, 2019·Current Topics in Medicinal Chemistry·Xiaopeng PengJianjun Chen
Oct 12, 2017·Archives of Toxicology·Soheila Rahmani, Mohammad Abdollahi
Nov 21, 2012·International Journal of Oncology·Bo Ra You, Woo Hyun Park
Nov 1, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Lulu LiuMingtai Chen
Nov 9, 2020·Clinical Epigenetics·Ping Zhang, Mingzhi Zhang
Apr 14, 2021·International Journal of Immunopathology and Pharmacology·Liangliang LiLi Zhao
Jul 24, 2021·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Fernando Hernández-BorjaMiguel A Vazquez
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sheng YangMei Dong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.